AstraZeneca bond offering admitted to trading on regulated market
AstraZeneca PLC (AZN) announced admission to trading on a regulated market for a €2.55 billion bond offering, citing FCA Prospectus Rules (PRM) sourcebook 1.5.2 and 1.5.3R.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.